Anti-FUT8 monoclonal antibody

Pre-made anti-FUT8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FUT8/FUT8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0871-Ab-1/ GM-Tg-hg-IP0871-Ab-2Anti-Human FUT8 monoclonal antibodyHuman
GM-Tg-rg-IP0871-Ab-1/ GM-Tg-rg-IP0871-Ab-2Anti-Rat FUT8 monoclonal antibodyRat
GM-Tg-mg-IP0871-Ab-1/ GM-Tg-mg-IP0871-Ab-2Anti-Mouse FUT8 monoclonal antibodyMouse
GM-Tg-cynog-IP0871-Ab-1/ GM-Tg-cynog-IP0871-Ab-2Anti-Cynomolgus/ Rhesus macaque FUT8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0871-Ab-1/ GM-Tg-felg-IP0871-Ab-2Anti-Feline FUT8 monoclonal antibodyFeline
GM-Tg-cang-IP0871-Ab-1/ GM-Tg-cang-IP0871-Ab-2Anti-Canine FUT8 monoclonal antibodyCanine
GM-Tg-bovg-IP0871-Ab-1/ GM-Tg-bovg-IP0871-Ab-2Anti-Bovine FUT8 monoclonal antibodyBovine
GM-Tg-equg-IP0871-Ab-1/ GM-Tg-equg-IP0871-Ab-2Anti-Equine FUT8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0871-Ab-1/ GM-Tg-hg-IP0871-Ab-2; GM-Tg-rg-IP0871-Ab-1/ GM-Tg-rg-IP0871-Ab-2;
GM-Tg-mg-IP0871-Ab-1/ GM-Tg-mg-IP0871-Ab-2; GM-Tg-cynog-IP0871-Ab-1/ GM-Tg-cynog-IP0871-Ab-2;
GM-Tg-felg-IP0871-Ab-1/ GM-Tg-felg-IP0871-Ab-2; GM-Tg-cang-IP0871-Ab-1/ GM-Tg-cang-IP0871-Ab-2;
GM-Tg-bovg-IP0871-Ab-1/ GM-Tg-bovg-IP0871-Ab-2; GM-Tg-equg-IP0871-Ab-1/ GM-Tg-equg-IP0871-Ab-2
Products NameAnti-FUT8 monoclonal antibody
Formatmab
Target NameFUT8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FUT8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0871-Ag-1Recombinant multi-species FUT8/ CDGF protein


    Target information

    Target IDGM-IP0871
    Target NameFUT8
    Gene ID2530,53618,432392,708839,448804,101089525,281177,100052546
    Gene Symbol and Synonymsalpha1-6FucT,CDGF,CDGF1,FUT8
    Uniprot AccessionQ9BYC5,Q6EV76,Q659X0,Q9N0W2
    Uniprot Entry NameFUT8_HUMAN,FUT8_RAT,FUT8_CANLF,FUT8_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000033170
    Target ClassificationN/A

    The target: FUT8, gene name: FUT8, also named as CDGF. This gene encodes an enzyme belonging to the family of fucosyltransferases. The product of this gene catalyzes the transfer of fucose from GDP-fucose to N-linked type complex glycopeptides. This enzyme is distinct from other fucosyltransferases which catalyze alpha1-2, alpha1-3, and alpha1-4 fucose addition. The expression of this gene may contribute to the malignancy of cancer cells and to their invasive and metastatic capabilities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.